Morrone Louis H.'s Form 4 filing
Abbott Laboratories (ABT) · filed Jan 30, 2025
- Accession no.
- 0001415889-25-002423
- Filed
- Jan 30, 2025
- Trade date
- Jan 28, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $336.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morrone Louis H.CIK 0001867666 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | Common shares without par value | SSaleDisposed | −2,644 | $127.39 | −$336,819.16 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.